6 citations
,
July 2019 in “Journal of Cosmetic Dermatology” In this study, the researchers reported that the hair transection rate during FUE surgery increased significantly by the end of the procedure, suggesting a higher workload affects the surgeon's performance.
30 citations
,
June 2008 in “Dermatologic Surgery” In this study, the SAFE System for follicular unit extraction demonstrated a favorable average follicle transection rate of 6.14% and is accessible for physicians with basic technical skills, showing promise for wider adoption.
January 2020 in “Hair transplant forum international” This study observed no significant relationship between previous hair restoration procedures and follicular transection rates in revision FUE, but noted potential trends worth investigating in further research.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study describes a novel cancer therapy, ONCO-NK-TRANSITION-GM1, that offers a 60-80% cure rate across multiple cancer types using existing pharmaceutical manufacturing technologies, and costs $50 per dose, presenting a more accessible alternative to current therapies.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers described ONCO-NK-TRANSITION-GM1, a cancer therapy that's manufacturable with current pharmaceutical methods, showing a 60-80% complete response rate across various cancer types and costing $50 per dose, providing a more accessible alternative to existing treatments.